Metformin reduces lipid accumulation in macrophages by inhibiting FOXO1-mediated transcription of fatty acid-binding protein 4 - PubMed (original) (raw)
. 2010 Feb 26;393(1):89-94.
doi: 10.1016/j.bbrc.2010.01.086. Epub 2010 Jan 25.
Affiliations
- PMID: 20102700
- DOI: 10.1016/j.bbrc.2010.01.086
Metformin reduces lipid accumulation in macrophages by inhibiting FOXO1-mediated transcription of fatty acid-binding protein 4
Jun Song et al. Biochem Biophys Res Commun. 2010.
Abstract
Objective: The accumulation of lipids in macrophages contributes to the development of atherosclerosis. Strategies to reduce lipid accumulation in macrophages may have therapeutic potential for preventing and treating atherosclerosis and cardiovascular complications. The antidiabetic drug metformin has been reported to reduce lipid accumulation in adipocytes. In this study, we examined the effects of metformin on lipid accumulation in macrophages and investigated the mechanisms involved.
Methods and results: We observed that metformin significantly reduced palmitic acid (PA)-induced intracellular lipid accumulation in macrophages. Metformin promoted the expression of carnitine palmitoyltransferase I (CPT-1), while reduced the expression of fatty acid-binding protein 4 (FABP4) which was involved in PA-induced lipid accumulation. Quantitative real-time PCR showed that metformin regulates FABP4 expression at the transcriptional level. We identified forkhead transcription factor FOXO1 as a positive regulator of FABP4 expression. Inhibiting FOXO1 expression with FOXO1 siRNA significantly reduced basal and PA-induced FABP4 expression. Overexpression of wild-type FOXO1 and constitutively active FOXO1 significantly increased FABP4 expression, whereas dominant negative FOXO1 dramatically decreased FABP4 expression. Metformin reduced FABP4 expression by promoting FOXO1 nuclear exclusion and subsequently inhibiting its activity.
Conclusions: Taken together, these results suggest that metformin reduces lipid accumulation in macrophages by repressing FOXO1-mediated FABP4 transcription. Thus, metformin may have a protective effect against lipid accumulation in macrophages and may serve as a therapeutic agent for preventing and treating atherosclerosis in metabolic syndrome.
Copyright 2010 Elsevier Inc. All rights reserved.
Similar articles
- Metformin reduces intracellular reactive oxygen species levels by upregulating expression of the antioxidant thioredoxin via the AMPK-FOXO3 pathway.
Hou X, Song J, Li XN, Zhang L, Wang X, Chen L, Shen YH. Hou X, et al. Biochem Biophys Res Commun. 2010 May 28;396(2):199-205. doi: 10.1016/j.bbrc.2010.04.017. Epub 2010 Apr 14. Biochem Biophys Res Commun. 2010. PMID: 20398632 - Regulatory effects of curcumin on lipid accumulation in monocytes/macrophages.
Zingg JM, Hasan ST, Cowan D, Ricciarelli R, Azzi A, Meydani M. Zingg JM, et al. J Cell Biochem. 2012 Mar;113(3):833-40. doi: 10.1002/jcb.23411. J Cell Biochem. 2012. PMID: 22021079 - FABP4 inhibition suppresses PPARγ activity and VLDL-induced foam cell formation in IL-4-polarized human macrophages.
Boss M, Kemmerer M, Brüne B, Namgaladze D. Boss M, et al. Atherosclerosis. 2015 Jun;240(2):424-30. doi: 10.1016/j.atherosclerosis.2015.03.042. Epub 2015 Apr 3. Atherosclerosis. 2015. PMID: 25897794 - Metformin, Macrophage Dysfunction and Atherosclerosis.
Feng X, Chen W, Ni X, Little PJ, Xu S, Tang L, Weng J. Feng X, et al. Front Immunol. 2021 Jun 7;12:682853. doi: 10.3389/fimmu.2021.682853. eCollection 2021. Front Immunol. 2021. PMID: 34163481 Free PMC article. Review. - A global perspective on FOXO1 in lipid metabolism and lipid-related diseases.
Li Y, Ma Z, Jiang S, Hu W, Li T, Di S, Wang D, Yang Y. Li Y, et al. Prog Lipid Res. 2017 Apr;66:42-49. doi: 10.1016/j.plipres.2017.04.002. Epub 2017 Apr 6. Prog Lipid Res. 2017. PMID: 28392404 Review.
Cited by
- Multi-omics analysis of the lipid-regulating effects of metformin in a glucose concentration-dependent manner in macrophage-derived foam cells.
Qi J, Dong M, Gou Q, Zhu H. Qi J, et al. Cell Biochem Biophys. 2024 Sep 5. doi: 10.1007/s12013-024-01269-x. Online ahead of print. Cell Biochem Biophys. 2024. PMID: 39235508 - The role of AMPK in macrophage metabolism, function and polarisation.
Cui Y, Chen J, Zhang Z, Shi H, Sun W, Yi Q. Cui Y, et al. J Transl Med. 2023 Dec 8;21(1):892. doi: 10.1186/s12967-023-04772-6. J Transl Med. 2023. PMID: 38066566 Free PMC article. Review. - ACSM5 inhibits ligamentum flavum hypertrophy by regulating lipid accumulation mediated by FABP4/PPAR signaling pathway.
Cao Y, Li J, Qiu S, Ni S, Duan Y. Cao Y, et al. Biol Direct. 2023 Nov 14;18(1):75. doi: 10.1186/s13062-023-00436-z. Biol Direct. 2023. PMID: 37957699 Free PMC article. - Adipokines in atherosclerosis: unraveling complex roles.
Luo J, He Z, Li Q, Lv M, Cai Y, Ke W, Niu X, Zhang Z. Luo J, et al. Front Cardiovasc Med. 2023 Aug 14;10:1235953. doi: 10.3389/fcvm.2023.1235953. eCollection 2023. Front Cardiovasc Med. 2023. PMID: 37645520 Free PMC article. Review. - Adipocyte "Fatty Acid Binding Protein" Gene Polymorphisms (rs1054135, rs16909196 and rs16909187) in Jordanians with Obesity and Type 2 Diabetes Mellitus.
El-Ryalat SW, Irshaid YM, Abujbara M, El-Khateeb M, Ajlouni KM. El-Ryalat SW, et al. Balkan J Med Genet. 2023 May 2;25(2):63-70. doi: 10.2478/bjmg-2022-0019. eCollection 2023 May. Balkan J Med Genet. 2023. PMID: 37265971 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous